Published March 2014 | Version Accepted Version
Journal Article Open

Transcriptional Control of Early T and B Cell Developmental Choices

  • 1. ROR icon California Institute of Technology

Abstract

T and B cells share a common somatic gene rearrangement mechanism for assembling the genes that code for their antigen receptors; they also have developmental pathways with many parallels. Shared usage of basic helixloop- helix E proteins as transcriptional drivers underlies these common features. However, the transcription factor networks in which these E proteins are embedded are different both in membership and in architecture for T and B cell gene regulatory programs. These differences permit lineage commitment decisions to be made in different hierarchical orders. Furthermore, in contrast to B cell gene networks, the T cell gene network architecture for effector differentiation is sufficiently modular so that E protein inputs can be removed. Complete T cell–like effector differentiation can proceed without T cell receptor rearrangement or selection when E proteins are neutralized, yielding natural killer and other innate lymphoid cells.

Additional Information

© 2014 Annual Reviews. Review in Advance first posted online on January 22, 2014. (Changes may still occur before final publication online and in print). Expected final online publication date for the Annual Review of Immunology Volume 32 is March 21, 2014. Please see http://www.annualreviews.org/catalog/pubdates.aspx for revised estimates. I am grateful to many colleagues for inspiring this review, and I especially thank the attendees of the FASEB Conferences on Molecular Mechanisms of Lymphocyte Development and Function and the Aegean Conferences on Gene Regulation in Lymphocyte Development for discussions, clarifications, and insights. I also thank members of my group for letting me refer to their own work before publication. Development of these ideas was supported by NIH grants CA148278, CA90233, HL89123, AI083514, and AI95943 and by the Albert Billings Ruddock Professorship. The author is not aware of any affiliations, memberships, funding, or financial holdings that might be perceived as affecting the objectivity of this review.

Attached Files

Accepted Version - nihms-572757.pdf

Files

nihms-572757.pdf

Files (914.6 kB)

Name Size
md5:46d4ba0cfd767186eed21b469beb95a4
914.6 kB Preview Download

Additional details

Identifiers

PMCID
PMC3994230
Eprint ID
43569
DOI
10.1146/annurev-immunol-032712-100024
Resolver ID
CaltechAUTHORS:20140130-091206404

Funding

NIH
CA148278
NIH
CA90233
NIH
HL89123
NIH
AI083514
NIH
AI95943
Albert Billings Ruddock Professorship

Dates

Created
2014-01-30
Created from EPrint's datestamp field
Updated
2021-11-10
Created from EPrint's last_modified field